outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1080,420,7250.4226239,1018.6707689,51605.120936,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4790,1791,0.2906357526,0.1209420531,0.6984265486,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4844,4180,0.6995573619,0.4738270117,1.0328252518,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1814,0.1947762898,0.0243803832,1.5560790322,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7937,0.3509887236,0.1759134828,0.7003049578,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4844,17684,0.5379247982,0.3995563886,0.7242108919,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1080,420,7153.0628244,1002.3936545,51044.125768,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1791,0.661756254,0.201976657,2.168177978,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4844,4180,0.7571088235,0.4921840015,1.164633082,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1814,0.1918118661,0.0239557769,1.5358212805,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7937,0.8131255877,0.2858916755,2.3126704207,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4844,17684,0.5607189552,0.3990131713,0.7879583163,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1080,420,7262.2229594,1018.4539224,51784.259607,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4790,1791,0.670226706,0.2077804998,2.1619152804,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4844,4180,0.7827620412,0.511408622,1.1980955869,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1080,1814,0.1909325495,0.0238359342,1.5294235194,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4790,7937,0.8083989845,0.2821855794,2.3158834673,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4844,17684,0.5568084735,0.3935044171,0.7878835986,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1080,420,7090.8812814,994.01221891,50583.480153,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4790,1791,0.6428128869,0.1942867421,2.1267967287,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4844,4180,0.7228224637,0.4702677691,1.1110102549,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1080,1814,0.1933898532,0.0241483604,1.5487442896,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4790,7937,0.8129516315,0.285673294,2.3134481559,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4844,17684,0.5650116242,0.4019793195,0.7941655701,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1080,420,7243.412092,1015.9233407,51644.663166,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4790,1791,0.6582300844,0.2028647114,2.1357427863,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4844,4180,0.7528819699,0.492300695,1.151392363,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1080,1814,0.192193319,0.0239903865,1.5397114083,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4790,7937,0.8058833993,0.2809891637,2.311292168,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4844,17684,0.5601321372,0.3959430275,0.7924069608,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.5132151648,0.4388510725,5.2177612824,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.7727830204,0.4676162822,1.277101802,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.8669581465,0.7080178201,1.0615784046,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,1.0931993035,0.5643220539,2.1177352701,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.8875396647,0.6284318321,1.2534798783,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17779,0.6847674295,0.593633873,0.7898916382,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.6886268105,0.4661439509,6.1171243343,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.783294556,0.4231952748,1.4498043763,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4863,4229,1.3322279939,1.0497551758,1.6907098613,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,1.2488471455,0.5926667745,2.6315279683,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.9628000426,0.641490593,1.4450467897,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17779,1.0081761728,0.8360329501,1.2157645165,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,1.804856779,0.4987504357,6.5313386406,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,0.8390003108,0.4512054018,1.5600910777,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4863,4229,1.4108501149,1.1119900382,1.7900322649,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1814,1.2323874412,0.5849605181,2.5963783164,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.9446851633,0.6286441162,1.4196109288,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4863,17779,0.9824791681,0.8134185931,1.1866772212,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,1.6625980704,0.4593557432,6.017628787,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,0.7492765387,0.4048851187,1.3866040159,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4863,4229,1.2512546569,0.9846957526,1.5899715341,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,1.2652495869,0.6005819532,2.6655088594,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.9600782472,0.6396121373,1.4411081138,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4863,17779,1.0195385742,0.8456393526,1.2291988319,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,1.8103080235,0.5008625738,6.543142393,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,0.8185755035,0.4396360876,1.524137517,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4863,4229,1.3369622999,1.0525741334,1.6981874574,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,1.2442950687,0.59070271,2.6210650327,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.9393510871,0.625008731,1.4117890216,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4863,17779,0.9905462374,0.8205220847,1.1958018762,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1070,417,1.1102660471,0.4490838304,2.7449010899,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4740,1753,0.5399696278,0.3778491527,0.7716497361,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4646,3983,0.7861957337,0.6644945096,0.9301863638,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1795,0.4952887369,0.3027234409,0.8103466719,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7855,0.4717804346,0.3702041558,0.6012271202,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4646,17225,0.4736049987,0.4186639538,0.5357559274,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1070,417,2.462120781,0.9066612391,6.6861121649,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4740,1753,0.8044345127,0.5283458014,1.2247942229,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4646,3983,1.3152289177,1.0732850367,1.6117126828,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1795,0.965839899,0.5111911342,1.8248491573,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7855,0.664888263,0.4951399767,0.892831165,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4646,17225,0.8105825533,0.6874506478,0.9557690836,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1070,417,2.4803789367,0.9135698653,6.7343285975,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4740,1753,0.8094845961,0.5314927982,1.2328771218,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4646,3983,1.3255137595,1.0836375029,1.6213786641,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1070,1795,0.9672175399,0.5115110268,1.8289141789,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4740,7855,0.6646627366,0.4944123755,0.8935386236,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4646,17225,0.8077956753,0.6833131036,0.9549558609,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1070,417,2.4484767451,0.9016381085,6.6490516704,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4740,1753,0.787494892,0.5170955163,1.1992913985,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4646,3983,1.2674700338,1.0355253885,1.5513673584,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1070,1795,0.9707771128,0.5140352509,1.8333532596,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4740,7855,0.6650111665,0.4952642502,0.8929371572,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4646,17225,0.8166411491,0.6922711299,0.9633548729,1,1
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1070,417,2.4876387304,0.9160351189,6.7555777338,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4740,1753,0.7986645596,0.5239658505,1.2173791062,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4646,3983,1.2836206637,1.0500493812,1.5691471638,1,1
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1070,1795,0.9704027604,0.5134110337,1.8341668868,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4740,7855,0.6631653074,0.4933676089,0.8914006858,1,1
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4646,17225,0.812065544,0.6867742172,0.9602143342,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1069,420,21692.297307,11543.078168,40765.188938,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4770,1788,0.6221128341,0.3362038112,1.1511599972,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4734,4105,0.6743771651,0.5479135292,0.8300298069,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1069,1807,0.5912056257,0.2850644506,1.2261230438,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4770,7918,0.5513211814,0.372413798,0.8161755731,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4734,17501,0.5164893499,0.4402779379,0.6058928363,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,1069,420,31143.074299,14892.902273,65124.383346,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4770,1788,1.2159167471,0.5501670665,2.6872810564,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,4734,4105,1.0541755138,0.8174861263,1.3593943409,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1069,1807,0.9958651904,0.4377225395,2.2656989029,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4770,7918,1.0454607892,0.5664208597,1.9296398482,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4734,17501,0.7977484692,0.6440853308,0.9880719054,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1069,420,31605.347296,15113.031678,66095.142191,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4770,1788,1.2086042623,0.5524806056,2.6439376299,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4734,4105,1.0614486004,0.830158865,1.3571777388,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1069,1807,0.9999157267,0.4393082287,2.2759224506,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4770,7918,1.0473277543,0.5737776275,1.9117082515,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4734,17501,0.7891573582,0.6314911266,0.9861885777,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1069,420,30989.636026,14821.773718,64793.698738,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4770,1788,1.1987817742,0.5438265748,2.6425294547,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4734,4105,1.0289774424,0.7958733971,1.3303555324,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1069,1807,0.9990619545,0.4391397867,2.2729090355,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4770,7918,1.0451469957,0.5665743117,1.9279593516,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4734,17501,0.7999083238,0.6459441807,0.9905706182,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1069,420,31604.765731,15116.881568,66075.877645,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4770,1788,1.1971747982,0.5484826245,2.6130773036,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4734,4105,1.0396459152,0.8108634715,1.332978568,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1069,1807,1.0022030007,0.4403214095,2.2810856633,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4770,7918,1.0447538133,0.5736807832,1.9026444013,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4734,17501,0.7899124701,0.6322114682,0.9869509521,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1080,421,6600.2847568,2120.5862268,20543.262199,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4772,1788,0.8797514859,0.4558305253,1.6979176118,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4763,4126,0.7760005654,0.6339829639,0.9498313231,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1811,0.4571553146,0.1260596195,1.6578741269,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4772,7906,0.5822418129,0.4043517096,0.8383927178,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4763,17456,0.5394215851,0.4643251016,0.6266636146,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,1080,421,5694.3977364,1524.5946166,21268.713156,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4772,1788,1.2416885253,0.4905903745,3.1427245089,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,4763,4126,1.2781909517,0.9957365654,1.6407674137,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1811,0.424983803,0.0993349747,1.8182038432,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4772,7906,0.9447558331,0.5713764495,1.5621287596,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4763,17456,0.8596584461,0.6993208937,1.0567575637,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1080,421,5780.3039125,1546.911944,21599.104881,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4772,1788,1.2513585636,0.49637977,3.154637536,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4763,4126,1.3081733166,1.0228549407,1.673079298,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1080,1811,0.4231663583,0.0988975015,1.8106601688,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4772,7906,0.937333795,0.565024155,1.5549682885,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4763,17456,0.8502725357,0.6892926056,1.0488483106,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1080,421,5660.9915702,1514.5269791,21159.626734,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4772,1788,1.2183352939,0.4809730897,3.0861204509,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4763,4126,1.2431937346,0.9640734313,1.6031254586,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1080,1811,0.4269969515,0.0997697827,1.8274711209,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4772,7906,0.9434872687,0.5707278056,1.5597071275,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4763,17456,0.8628774377,0.7020196189,1.0605935395,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1080,421,5775.7510708,1544.7915598,21594.693614,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4772,1788,1.2348904288,0.4896145325,3.1146019362,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4763,4126,1.2776854853,0.9947268138,1.6411342056,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1080,1811,0.4246756591,0.0992099921,1.8178553541,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4772,7906,0.933985218,0.563027211,1.5493538685,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4763,17456,0.8521857722,0.6909566658,1.0510363764,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1078,421,26670.101657,11014.061905,64580.563333,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4784,1794,0.7691697263,0.2769756062,2.136007845,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4819,4186,0.5719419203,0.4314754063,0.7581372088,1,1
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1078,1813,1.5345804076,0.4440961117,5.3027643468,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4784,7924,0.5802069893,0.3106302584,1.0837326414,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4819,17632,0.5228315421,0.4174741387,0.6547778558,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,1078,421,60720.686197,21084.238939,174870.04122,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4784,1794,1.7537076294,0.4233331184,7.2649417579,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,4819,4186,0.9046523606,0.6404336405,1.2778777406,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1078,1813,4.012031387,1.0103177305,15.932013628,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4784,7924,1.1929838121,0.3779345821,3.7657585285,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4819,17632,0.797014951,0.5927181336,1.0717283581,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1078,421,73872.029021,25730.232021,212088.12525,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4784,1794,1.8168606893,0.451848006,7.3055158376,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4819,4186,0.9835118349,0.6935397899,1.3947224708,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1078,1813,4.0046330978,1.007174296,15.922851001,1,1
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4784,7924,1.1767683858,0.3886636508,3.5629363102,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4819,17632,0.7624688516,0.5576449662,1.0425248768,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1078,421,60218.188144,20891.583279,173573.73709,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4784,1794,1.7132649275,0.4160069969,7.055834959,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4819,4186,0.8757362132,0.6157809473,1.2454330041,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1078,1813,4.044674017,1.017850602,16.072484382,1,1
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4784,7924,1.190518195,0.3778255151,3.7512913136,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4819,17632,0.8009151982,0.5959790659,1.0763216218,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1078,421,74380.361018,25881.689968,213758.76584,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4784,1794,1.7973102455,0.4491651782,7.1918400527,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4819,4186,0.9573565036,0.6709254021,1.3660706126,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1078,1813,4.0326222863,1.0135581115,16.044509259,1,1
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4784,7924,1.1683413319,0.388920644,3.5097686095,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4819,17632,0.7651919084,0.5599586496,1.0456462402,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.3599284833,0.6745038057,2.74187553,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.8602589799,0.6970679725,1.0616547335,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.7880977528,0.7260204433,0.8554828912,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,0.7340869106,0.5132350059,1.0499743511,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.7199667884,0.6338863536,0.8177367654,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17779,0.6721540246,0.6320442409,0.7148091915,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,2.1099562991,0.9886642988,4.5029597907,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.9828568136,0.7554931159,1.2786450276,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.8667581956,0.7822896601,0.9603473085,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,1.0789350937,0.7040980375,1.6533222286,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.850589472,0.7129716412,1.0147703052,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17779,0.7458222978,0.6858808972,0.8110021757,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,2.296285811,1.0750481208,4.9048302342,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,1.0645231771,0.8187073966,1.3841448109,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4863,4229,0.9429682944,0.8518743898,1.0438031885,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1814,1.056841094,0.6894571796,1.619989074,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.8233505913,0.6920635194,0.9795433182,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4863,17779,0.7108927812,0.6523711535,0.7746641518,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,2.1182349145,0.993485216,4.5163421465,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,1.0008967006,0.7692811793,1.3022471267,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4863,4229,0.8921777686,0.8044356651,0.9894901549,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,1.0733265207,0.7004425121,1.6447171609,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.8520437744,0.7139088159,1.0169066095,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4863,17779,0.7447197144,0.6851670217,0.8094485512,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,2.2885938177,1.0724895535,4.8836481859,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,1.07422594,0.8263423439,1.3964688834,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4863,4229,0.9636798051,0.8698398267,1.0676434192,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,1.052614891,0.6866835573,1.6135497888,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7952,0.8258221519,0.6937722772,0.9830058781,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4863,17779,0.7100960578,0.6518524505,0.7735437843,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,0.958505575,0.3520811331,2.6094353003,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.8344420302,0.5759504926,1.2089467945,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.8742466066,0.7421905946,1.029798996,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,1.6479708248,0.8134575131,3.3385982617,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7952,1.3294657019,1.02611632,1.7224938519,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17779,0.9492429406,0.8381520664,1.0750580907,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.0432352444,0.3119207078,3.4891552493,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.9711781807,0.6236027511,1.5124805928,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.9555669376,0.7732791277,1.1808260944,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,2.1091543918,0.8079568476,5.5059032689,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7952,1.1704060824,0.8281513568,1.6541063256,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17779,1.0322486841,0.8641585582,1.2330345348,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,1.0988568349,0.3285291599,3.6754312581,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,1.018561557,0.6538532239,1.5866980652,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4863,4229,1.0121979374,0.8237836914,1.243705933,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1814,2.0732432978,0.7931006727,5.4196622441,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7952,1.143388611,0.8075778057,1.6188378465,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4863,17779,1.0048803111,0.8368702658,1.2066200472,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,1.0592566548,0.316769105,3.5420899413,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,1.0040204799,0.6443402431,1.5644795353,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4863,4229,1.0044183549,0.8124314958,1.2417739058,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,2.089772224,0.803151229,5.4375163611,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7952,1.1741862578,0.830934497,1.6592323138,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4863,17779,1.0248790082,0.8579019972,1.2243554448,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,1.1027208728,0.3299346273,3.6855583578,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,1.0387465389,0.6668540882,1.6180366756,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4863,4229,1.0533238261,0.8566867169,1.2950954657,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,2.0593398897,0.7901814429,5.3669708637,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7952,1.1502994988,0.8124083282,1.628723994,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4863,17779,1.0000881253,0.8324957413,1.2014190689,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1032,407,1.5872095759,0.6059439967,4.1575364252,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4595,1737,2.33049276,1.335798018,4.0658815412,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4514,3966,1.469375447,1.0966012977,1.9688689122,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1032,1786,1.0761392642,0.6418981182,1.8041425627,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4595,7840,1.5030154502,1.1522730247,1.9605209835,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4514,17422,1.0342588924,0.8543751446,1.2520161234,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1032,407,1.8269152445,0.6706948677,4.9763602961,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4595,1737,2.4527253722,1.327861142,4.5304900952,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4514,3966,1.7782060397,1.2361113977,2.5580354047,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1032,1786,1.0346705124,0.5784965178,1.8505609562,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4595,7840,1.4780824051,1.0848341487,2.0138816602,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4514,17422,1.2242249211,0.9241970269,1.6216527578,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1032,407,1.9925200388,0.7282852412,5.4513477416,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4595,1737,2.6499391256,1.4267726878,4.9217211887,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4514,3966,1.9425103187,1.3446119938,2.806271516,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1032,1786,1.0196430149,0.5696229818,1.8251929979,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4595,7840,1.4510038761,1.0640439683,1.9786891436,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4514,17422,1.1926215198,0.8987248677,1.5826268311,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1032,407,1.8271480284,0.6707853841,4.9769568577,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4595,1737,2.4545773541,1.3290082084,4.5334181904,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4514,3966,1.7802061737,1.2433550972,2.5488567408,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1032,1786,1.0344823554,0.5784308831,1.8500978678,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4595,7840,1.4780593201,1.0848251298,2.0138354964,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4514,17422,1.2239718634,0.9227105431,1.623593806,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1032,407,1.9941172452,0.7287818782,5.4563700153,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4595,1737,2.6477781268,1.4256542889,4.9175519363,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4514,3966,1.9387258096,1.3467516602,2.7909063533,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1032,1786,1.0199390135,0.5698321157,1.8255825929,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4595,7840,1.4509574459,1.0640033089,1.9786381228,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4514,17422,1.1930968988,0.8980108387,1.585148139,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1060,414,5.7725241265,0.7699168704,43.280042395,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4681,1776,0.9823330697,0.6169733984,1.564051647,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4694,4072,1.3765038204,1.0390813292,1.8234980404,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1060,1798,1.0894650082,0.5967567039,1.9889747299,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4681,7898,1.2713764824,0.9587819584,1.6858871257,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4694,17599,1.2613944149,1.0414459291,1.5277949873,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1060,414,8.4040308618,1.0618003837,66.51696101,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4681,1776,0.667040648,0.3849197601,1.1559376062,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4694,4072,1.5649765339,1.1059120079,2.2145989323,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1060,1798,1.1310907322,0.5003955049,2.5567101065,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4681,7898,1.1138869089,0.8059053196,1.5395655242,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4694,17599,1.3665239382,1.0407962178,1.7941914486,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1060,414,8.684316793,1.0971484468,68.739429367,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4681,1776,0.686810204,0.3970588472,1.1880059079,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4694,4072,1.6099479724,1.1420510867,2.2695416205,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1060,1798,1.1225266207,0.4960270903,2.5403169279,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4681,7898,1.1009898519,0.7947375913,1.5252564712,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4694,17599,1.3489345253,1.024906646,1.7754049705,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1060,414,8.4109340136,1.0627079371,66.569382337,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4681,1776,0.6691428871,0.3853116253,1.162052152,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4694,4072,1.5727768232,1.1174521753,2.2136311426,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1060,1798,1.1302609469,0.4998746408,2.5556203572,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4681,7898,1.1139180362,0.8059309943,1.5396025219,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4694,17599,1.3654315268,1.038597827,1.7951156895,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1060,414,8.6821296481,1.0968181748,68.72549795,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4681,1776,0.6877988339,0.3971231517,1.1912355998,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4694,4072,1.6146709849,1.1508907378,2.2653430982,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1060,1798,1.1221274569,0.4957603512,2.5398764272,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4681,7898,1.101251596,0.7947440167,1.5259694344,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4694,17599,1.3484176143,1.0235922501,1.7763226151,1,1
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1080,420,837458.48912,267325.72184,2623528.7655,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,365672.78219,163818.83895,816246.68134,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4852,4219,1.7437160503,0.7707554466,3.9448902728,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1813,4.5790000802,0.47551925,44.093360537,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7949,1.6656873058,0.50920377,5.448730674,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4852,17762,1.1757498673,0.7013628158,1.971002339,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,1080,420,948555.03484,278042.12204,3236044.4076,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,190168.13824,80183.708829,451013.32089,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,4852,4219,2.597629243,1.0634029259,6.3453630981,1,1
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1080,1813,6.5710232783,0.6565275083,65.767765065,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7949,1.1517132363,0.3373863382,3.9315266458,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4852,17762,1.5294192987,0.8242943889,2.8377281501,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1080,420,954449.6544,272560.35482,3342284.1094,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4791,1798,191288.13887,78903.113476,463747.88599,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4852,4219,2.664529731,1.1159147309,6.3622412097,1,1
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1080,1813,6.5438389056,0.6551081363,65.366044552,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4791,7949,1.1537208791,0.3388238238,3.928507305,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4852,17762,1.5375923189,0.8100620964,2.9185295172,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1080,420,955919.83006,280330.81477,3259658.494,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4791,1798,196288.58192,82668.744525,466067.40688,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4852,4219,2.7183311612,1.0808982042,6.8362814121,1,1
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1080,1813,6.5153680919,0.6503423568,65.273345535,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4791,7949,1.1548994032,0.3382718365,3.9429609195,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4852,17762,1.5222875776,0.82316595,2.8151789674,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1080,420,956362.38351,273010.45277,3350161.136,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4791,1798,196614.3069,81386.328632,474983.77588,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4852,4219,2.7667798249,1.13270286,6.7582336637,1,1
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1080,1813,6.5009489454,0.6502925481,64.989730107,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4791,7949,1.1606954995,0.3407091328,3.9541471384,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4852,17762,1.5344845292,0.8081840175,2.9134983118,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,805157.46899,198234.16608,3270266.4868,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4792,1799,0.2879995392,0.0404100172,2.0525538073,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4857,4222,1.4615645509,0.6144620501,3.476489616,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,798944.98261,198246.73758,3219791.12,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7952,0.7093458056,0.1297489939,3.878037563,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4857,17773,2.0740600381,1.1425184624,3.7651251889,1,1
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,899890.29882,209651.77261,3862607.6939,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1799,0.8372754325,0.0894141867,7.8402564058,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4857,4222,1.2892835516,0.4887652094,3.4009214332,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,894717.2015,210534.46722,3802317.4125,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7952,1.5832701222,0.2099885985,11.937525647,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4857,17773,1.6852334024,0.7907816186,3.5913981226,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,824736.28057,189801.1226,3583698.1529,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4792,1799,0.7621798517,0.0839396719,6.9206623464,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4857,4222,1.2227916288,0.4727480415,3.1628250913,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1814,941190.57987,221820.62126,3993495.7472,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4792,7952,1.6198822347,0.2118043303,12.38888011,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4857,17773,1.7163693382,0.7871101303,3.7427084112,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,899155.03446,209851.10446,3852635.3153,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4792,1799,0.8340023171,0.0874699395,7.9519874967,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4857,4222,1.2807958123,0.4639968944,3.5354501995,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,895617.30965,210264.81504,3814857.7793,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4792,7952,1.5834584931,0.2101373435,11.931914421,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4857,17773,1.6869725128,0.7980773714,3.5659152373,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,824765.6372,190138.41272,3577595.6397,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4792,1799,0.7613675648,0.0825232234,7.024453784,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4857,4222,1.2206631227,0.4550912241,3.2741094093,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,941312.7726,221502.72838,4000265.5603,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4792,7952,1.6195189599,0.210761772,12.444579665,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4857,17773,1.7166436794,0.7910174467,3.7254115371,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.0105748507,0.8839380293,1.1553542161,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,1.1252407209,0.125702744,10.072705178,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4840,4188,0.5555241547,0.3677180968,0.8392491126,1,1
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,0.9985670924,0.9155795697,1.089076549,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7947,2.80079791,0.5131405046,15.287175465,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4840,17724,1.0022475333,0.7049065276,1.4250117975,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.0227380791,0.8639213506,1.2107504667,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,1.1320184115,0.1241073553,10.325461216,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4840,4188,0.9283751099,0.5523894064,1.5602767446,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1814,1.0098944644,0.9028820519,1.1295903236,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7947,2.045347819,0.3585574897,11.667439171,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4840,17724,1.6683656466,1.0413713661,2.6728638999,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,1.1318949626,0.9055334426,1.414841403,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4791,1798,1.4109633912,0.1539765542,12.929356042,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4840,4188,1.1500198125,0.7012990706,1.8858510224,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1814,0.9990148024,0.8796113976,1.1346266977,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4791,7947,1.8808554276,0.3287109874,10.762089724,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4840,17724,1.5156916336,0.9264259217,2.4797677551,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,1.0302990988,0.8680705143,1.2228456279,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4791,1798,1.1551711112,0.1265373949,10.545659622,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4840,4188,0.9561705977,0.5710693222,1.6009653755,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,1.0042275361,0.8947078375,1.127153359,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4791,7947,2.0476084977,0.3589359963,11.680914156,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4840,17724,1.6615533927,1.0357138134,2.6655622826,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,1.1434733076,0.9117803961,1.4340418053,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4791,1798,1.4122797038,0.1541826935,12.936172777,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4840,4188,1.1642041408,0.7132500096,1.9002751676,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1814,0.9974128815,0.8775984513,1.1335850181,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4791,7947,1.8819315581,0.3288437574,10.770058149,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4840,17724,1.5113234798,0.9222031033,2.4767848344,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1076,419,19868.499142,9841.3313309,40112.180445,0,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4769,1783,1.0620742495,0.5633770454,2.0022145393,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4736,4088,0.8955279827,0.7328704929,1.0942866108,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1076,1804,0.4708657999,0.2131314853,1.0402714609,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7908,0.8060379133,0.560594097,1.1589439154,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4736,17562,0.85674392,0.7382879209,0.9942058154,1,1
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,1076,419,22194.568447,9183.9362868,53637.008488,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4769,1783,1.1598285178,0.4516429616,2.978463754,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,4736,4088,1.1128480808,0.8775087445,1.411303145,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1076,1804,0.6054775171,0.2328969249,1.5740998894,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7908,1.0233223927,0.5523769174,1.8957865298,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4736,17562,1.0146649913,0.83813642,1.2283740689,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1076,419,23727.443912,9812.6393798,57374.124617,0,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4769,1783,1.215038147,0.4765596596,3.0978654377,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4736,4088,1.1691941092,0.9279940136,1.4730858658,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1076,1804,0.5989240553,0.2303697233,1.5571057642,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4769,7908,1.0056421985,0.5511368403,1.8349639462,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4736,17562,0.9832869959,0.8042460806,1.2021859224,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1076,419,22121.682258,9160.6874868,53420.534937,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4769,1783,1.1455676523,0.4469974381,2.9358674883,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4736,4088,1.093498856,0.8634331548,1.3848666123,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1076,1804,0.6078462184,0.2338023593,1.5802963939,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4769,7908,1.0225769954,0.5523201091,1.8932204248,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4736,17562,1.0170788992,0.8399997245,1.2314878887,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1076,419,23732.922723,9818.2554456,57367.790449,0,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4769,1783,1.2055463196,0.4735045506,3.0693304361,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4736,4088,1.1505296211,0.9135345634,1.4490074729,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1076,1804,0.6009363125,0.231163579,1.5622030654,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4769,7908,1.0032230775,0.5510962408,1.8262809083,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4736,17562,0.9849312265,0.8056800542,1.2040629725,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.0071855078,0.8785978735,1.15459265,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.5723602646,0.0524007128,6.2517522147,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4860,4224,7.3794167794,0.9411155054,57.863027112,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1812,1.0014861529,0.9167671423,1.094034099,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7951,2389920.9392,601941.55366,9488831.6995,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17768,1.3813565255,0.6689164185,2.8525923383,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.0153784996,0.8454684844,1.2194345695,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,1.2766859424,0.117254596,13.900751446,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4860,4224,8.5887991647,1.0154162318,72.647520084,1,1
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1812,1.0052677229,0.8877639849,1.1383241625,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7951,1185377.6748,301541.38551,4659792.3186,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17768,1.2990744516,0.5148498009,3.2778383672,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,0.9309407417,0.7206617192,1.2025762455,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,1.1843997453,0.109546504,12.805545644,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4860,4224,7.7321109764,0.907787457,65.858521937,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1812,1.0250067558,0.8985090857,1.1693135508,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7951,3379620.3946,844963.47104,13517547.685,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4860,17768,1.3506468275,0.52991305,3.4425399652,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,1.0484994089,0.8514062821,1.2912178753,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,1.3768281386,0.1268104635,14.948732707,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4860,4224,9.5473911832,1.088791537,83.719128327,1,1
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1812,0.9824588833,0.8526096049,1.1320837249,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7951,1192055.965,302876.64022,4691670.5849,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4860,17768,1.2813282775,0.5123945561,3.2041756401,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,0.9495580302,0.7246601822,1.2442527888,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,1.2884678621,0.1194981454,13.892679478,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4860,4224,8.5520997311,0.9732041749,75.15217433,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1812,1.0078277428,0.8670685338,1.1714376888,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7951,3416196.2766,850562.22114,13720803.382,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4860,17768,1.3481249229,0.5284889248,3.4389383054,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,1.0025844035,0.8467814689,1.1870541847,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4791,1797,1.1473277299,0.3238761811,4.064395583,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4845,4208,0.7075189437,0.402573328,1.2434580754,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1812,6.5893066E-6,1.6407849E-6,0.0000264623,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7947,0.8117448679,0.400310023,1.6460485441,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17736,0.5910071761,0.3842156861,0.9090974022,1,1
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,0.9988574718,0.8433844476,1.1829910449,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4791,1797,0.4047765364,0.1022969874,1.6016507287,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,4845,4208,0.5124544477,0.2731501707,0.961410935,1,1
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1812,5.5576999E-6,1.3780345E-6,0.0000224146,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7947,0.5410522495,0.2440813932,1.1993439273,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17736,0.4295949121,0.2644700075,0.6978174587,1,1
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,1.0052206698,0.8289606087,1.2189585179,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4791,1797,0.4251083525,0.1062469838,1.7009152153,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4845,4208,0.5497241642,0.2903452214,1.0408184275,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1812,5.4078095E-6,1.3386116E-6,0.0000218468,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4791,7947,0.5378693113,0.2415010483,1.197938469,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4845,17736,0.4216953128,0.2593700373,0.6856109468,1,1
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,1.003343463,0.8467065284,1.1889575325,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4791,1797,0.409710455,0.1040024965,1.6140252648,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4845,4208,0.5217521168,0.2749382002,0.9901325865,1,1
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1812,5.5365485E-6,1.3725529E-6,0.0000223331,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4791,7947,0.5414943687,0.2443255566,1.200104301,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4845,17736,0.4283555807,0.2641563048,0.6946209503,1,1
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,1.008275485,0.8304831968,1.2241300696,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4791,1797,0.4275540991,0.1072194235,1.7049383568,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4845,4208,0.5579260144,0.292306087,1.0649160293,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1812,5.3920242E-6,1.3342431E-6,0.0000217906,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4791,7947,0.539071805,0.242155357,1.2000494826,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4845,17736,0.4207609517,0.2591367842,0.6831904588,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1076,420,2.4180067795,0.3043012184,19.213714677,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4776,1794,0.7106250391,0.3544593658,1.4246709072,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4740,4088,0.8117344719,0.6589900993,0.9998827806,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1076,1805,0.8729639265,0.3654274988,2.0854096082,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4776,7859,0.3948340376,0.2593622128,0.601066422,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4740,17213,0.5861181175,0.5031129532,0.682817736,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1076,420,2.3349416706,0.2846840895,19.150886216,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4776,1794,1.2332889077,0.5571453089,2.7299907324,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4740,4088,0.9657333154,0.7507888265,1.2422145929,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1076,1805,0.7900982385,0.3068514351,2.0343891377,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4776,7859,0.6005748318,0.3418081543,1.0552414392,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4740,17213,0.6985533923,0.5725547634,0.8522797697,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1076,420,2.3892576772,0.2910554877,19.613278187,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4776,1794,1.2609405141,0.5699058962,2.789883366,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4740,4088,1.0107778181,0.7848854763,1.3016826384,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1076,1805,0.7835508178,0.3045132721,2.0161744668,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4776,7859,0.5926204475,0.3366551814,1.0432009194,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4740,17213,0.6836438877,0.5592455166,0.8357133876,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1076,420,2.3450568312,0.2858294477,19.239765484,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4776,1794,1.2509348339,0.5642781872,2.7731675514,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4740,4088,0.9849148789,0.7613809111,1.2740762271,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1076,1805,0.7867185932,0.3054348688,2.0263768422,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4776,7859,0.60167652,0.3423660912,1.0573904486,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4740,17213,0.6968040342,0.5718640765,0.8490406761,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1076,420,2.3883426301,0.2908191325,19.614185869,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4776,1794,1.2721050668,0.5744585138,2.8170029027,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4740,4088,1.0272533294,0.7941000078,1.3288620984,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1076,1805,0.7807828648,0.3033237155,2.0098061933,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4776,7859,0.5946985394,0.3376644638,1.0473899112,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4740,17213,0.6824167612,0.5587457326,0.8334607475,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1069,416,1.3392945632,0.4540129319,3.9507903869,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4757,1785,1.0790408783,0.6473566289,1.7985900893,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4691,4050,0.8111618836,0.6855481925,0.959791899,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1069,1799,0.5637904264,0.327972827,0.9691645733,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4757,7871,1.0191857209,0.7603523109,1.3661292519,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4691,17388,0.8017805869,0.7053077248,0.9114491263,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1069,416,1.8362334384,0.5491154297,6.1403359978,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4757,1785,1.1779499439,0.6755453553,2.0539939463,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4691,4050,1.0022987491,0.7972626649,1.2600650032,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1069,1799,0.7879409799,0.3805128925,1.6316161689,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4757,7871,1.1031805942,0.7838500547,1.5526023326,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4691,17388,0.9740352508,0.8016979593,1.1834190905,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1069,416,1.9073234113,0.5707918406,6.3733962829,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4757,1785,1.2231288796,0.6993558657,2.1391745312,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4691,4050,1.0448070382,0.8391325037,1.3008931753,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1069,1799,0.7818979038,0.3771909479,1.620835111,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4757,7871,1.0905434633,0.7743351029,1.5358790282,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4691,17388,0.9561039077,0.780801816,1.1707640321,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1069,416,1.8567063181,0.55390266,6.2237620445,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4757,1785,1.2142226681,0.6962954246,2.1174010852,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4691,4050,1.0455222497,0.8301990428,1.3166924054,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1069,1799,0.7801809901,0.3755889362,1.6206078472,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4757,7871,1.1062463453,0.7859278589,1.5571161688,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4691,17388,0.9668169702,0.796072535,1.1741832721,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1069,416,1.9076266625,0.5694262095,6.3907130075,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4757,1785,1.2457899314,0.7128100886,2.1772875806,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4691,4050,1.0813034061,0.8667930427,1.3488999086,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1069,1799,0.7760556029,0.3733305659,1.6132145444,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4757,7871,1.0971017339,0.7789073718,1.5452828643,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4691,17388,0.9512683495,0.7770256344,1.1645838087,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1059,416,3.1159720698,0.9562340186,10.153667147,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4662,1759,1.6417947286,1.0916636296,2.4691579511,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4588,4034,1.3413698064,1.0917001809,1.6481383708,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1059,1798,1.8599115722,1.092818709,3.165457388,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4662,7887,2.0380185839,1.5949417931,2.6041826519,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4588,17525,1.6040270443,1.3826089371,1.8609041862,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1059,416,2.6982223581,0.7430638621,9.797817207,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4662,1759,1.0513545283,0.6238679449,1.7717633244,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4588,4034,1.219147276,0.9516456091,1.5618419991,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1059,1798,1.2270086574,0.6034338125,2.4949716343,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4662,7887,1.5907292755,1.196341286,2.1151319088,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4588,17525,1.4758707948,1.2168070032,1.7900904558,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1059,416,2.6996353051,0.7413734016,9.8304454468,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4662,1759,1.0522806907,0.6253123217,1.7707865553,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4588,4034,1.2257730641,0.9571243734,1.5698269175,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1059,1798,1.2299419869,0.6050576393,2.5001870781,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4662,7887,1.5936399508,1.196521212,2.1225601915,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4588,17525,1.4730180745,1.2104676973,1.7925156142,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1059,416,2.6985369202,0.7431437348,9.7990485133,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4662,1759,1.0524899808,0.6235604461,1.7764679696,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4588,4034,1.2210926591,0.9528110259,1.5649139668,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1059,1798,1.2267344089,0.6032827388,2.4944809679,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4662,7887,1.5907542225,1.1963721934,2.1151436069,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4588,17525,1.4755333814,1.2162672293,1.7900661196,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1059,416,2.6988516879,0.7411174413,9.8281325297,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4662,1759,1.0532992949,0.6251950034,1.7745493783,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4588,4034,1.2278464436,0.9585769224,1.5727552519,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1059,1798,1.2296945493,0.6049092168,2.4997944197,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4662,7887,1.5938873446,1.1966908978,2.1229181838,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4588,17525,1.4727878497,1.2101583036,1.7924134749,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1037,403,1.2287805857,0.5348671985,2.8229469518,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4548,1730,0.8143368384,0.5901845412,1.1236222573,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4404,3939,1.2449394689,0.9925498604,1.5615077318,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1037,1794,1.5483361734,0.9131664673,2.6253098332,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4548,7862,2.0265848076,1.5750571019,2.6075537056,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4404,17463,1.8989952695,1.6053999897,2.2462832046,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1037,403,1.4673935036,0.5943951048,3.6225797908,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4548,1730,0.7332293335,0.4975018064,1.080649856,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4404,3939,1.1459716668,0.8771080734,1.4972511379,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1037,1794,1.5634929888,0.8327329626,2.9355272769,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4548,7862,2.0451452525,1.5380453633,2.7194380633,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4404,17463,1.6870867199,1.3659475301,2.0837268911,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1037,403,1.5421753387,0.6247843947,3.8066007981,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4548,1730,0.7667845048,0.5222659364,1.125783697,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4404,3939,1.2024130509,0.9215265907,1.5689152755,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1037,1794,1.5462446161,0.8231402366,2.90457483,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4548,7862,2.0114215317,1.5100120137,2.6793274102,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4404,17463,1.6475747067,1.3315962517,2.0385326338,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1037,403,1.4736802466,0.5969297732,3.6381724731,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4548,1730,0.7430803445,0.5035027326,1.0966542238,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4404,3939,1.1715578018,0.8948954841,1.5337519378,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1037,1794,1.5589367499,0.8302319388,2.9272347603,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4548,7862,2.0444364069,1.5377438447,2.7180861338,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4404,17463,1.6820707483,1.3619358238,2.0774561862,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1037,403,1.5414154468,0.6244655406,3.8047921389,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4548,1730,0.7727072489,0.5259117382,1.1353169157,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4404,3939,1.2229354045,0.9357848063,1.5981997073,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1037,1794,1.5433520309,0.8215625367,2.8992747174,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4548,7862,2.0128587132,1.5111724525,2.6810971788,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4404,17463,1.6448107442,1.3292946027,2.0352165567,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1017,394,0.9362608575,0.4996034127,1.7545604592,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4488,1706,1.1984730518,0.8709235559,1.6492120877,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4540,3998,1.6853482988,1.3518741217,2.1010823735,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1017,1754,0.8738260855,0.5909722144,1.2920607925,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4488,7740,0.8661851602,0.7245003055,1.035578213,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4540,17477,1.4630124562,1.2637363431,1.69371203,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1017,394,0.8914255156,0.410324537,1.9366120672,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4488,1706,1.2605402154,0.8652629481,1.836391629,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4540,3998,1.4438158719,1.1118783564,1.8748492224,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1017,1754,0.9806841595,0.5927440145,1.6225240529,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4488,7740,0.8144023097,0.6615713871,1.0025390079,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4540,17477,1.242087098,1.0286850593,1.4997596641,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1017,394,0.8861116267,0.4078563674,1.9251723833,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4488,1706,1.2523137114,0.8602207934,1.8231245324,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4540,3998,1.4348147489,1.1056908861,1.8619067856,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1017,1754,0.9815637446,0.592990946,1.624759014,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4488,7740,0.8151491073,0.661307126,1.0047798383,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4540,17477,1.2432494313,1.027808685,1.5038490831,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1017,394,0.8847968925,0.4069615743,1.9236841766,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4488,1706,1.2395118793,0.8500964342,1.8073122497,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4540,3998,1.4080433265,1.0820792739,1.8322003361,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1017,1754,0.9847983947,0.594889797,1.6302647704,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4488,7740,0.8127263017,0.6600486681,1.0007202097,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4540,17477,1.2471676739,1.0331677699,1.5054933497,1,1
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1017,394,0.8833883673,0.4064122788,1.9201560786,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4488,1706,1.2364805754,0.8487483764,1.8013397797,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4540,3998,1.4043289459,1.0807062787,1.8248619695,1,1
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1017,1754,0.9844975738,0.5943821795,1.6306603835,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4488,7740,0.8122670547,0.6587239091,1.0015998495,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4540,17477,1.2465062746,1.0308248663,1.5073151058,1,1
